|Articles|April 1, 1998

Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach
Volume 4
Issue 4 Suppl

Part I: Scope of the Problem

Download PDF: Part I: Scope of the Problem

Articles in this issue

almost 28 years ago

Article

Participating Faculty

almost 28 years ago

Article

Introduction: Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach

almost 28 years ago

Article

Coronary Heart Disease in the United States

almost 28 years ago

Article

Mechanisms of Acute Coronary Events

almost 28 years ago

Article

Primary Prevention

almost 28 years ago

Article

Pravastatin Event Reduction Analysis

almost 28 years ago

Article

Secondary Prevention

almost 28 years ago

Article

Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?

almost 28 years ago

Article

Methods and Mindsets in Pharmacoeconomics

almost 28 years ago

Article

Issues and Controversies in Pharmacoeconomics

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Subjective and Objective Impacts of Ambulatory AI Scribes

ByJulia Adler-Milstein, PhD,Orianna DeMasi, PhD,Hossein Soleimani, PhD,Sarah Beck, MDiv,Maria E. Byron, MD,Aris Oates, MD,Robert Thombley, BS,Jinoos Yazdany, MD, MPH,Sara G. Murray, MD, MAS

January 8th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Part I: Scope of the Problem

Articles in this issue

Newsletter

Related Content

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Subjective and Objective Impacts of Ambulatory AI Scribes

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access

Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care

Semaglutide Shows Promise for Steatohepatitis Resolution in MASH

Balancing Innovation With Administrative Burdens in Cancer Care

Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma